Group D consisted of five conventional osteosarcomas exhibiting amplification of CDK4, rearrangements of TP53, and numerous genome-wide copy number and structural variants (Figs. 1 and 5A; Supplementary Figs. 20–22; Supplementary Table 1). This evidence concerns the gene CDK4 and osteosarcoma.